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a  b  s  t  r  a  c  t
Isoprene,  a possible  carcinogen,  is a petrochemical  and  a natural  product  being  primar-
ily produced  by  plants.  It is  biotransformed  to 2-ethenyl-2-methyloxirane  (IP-1,2-O)  and
2-(1-methylethenyl)oxirane  (IP-3,4-O),  both  of  which  can  be  further  metabolized  to 2-
methyl-2,2′-bioxirane  (MBO).  MBO  is  mutagenic,  but IP-1,2-O  and  IP-3,4-O  are  not.  While
IP-1,2-O has  been  reported  being  genotoxic,  the  genotoxicity  of  IP-3,4-O  and  MBO,  and  the
cross-linking  potential  of  MBO  have  not  been  examined.  In the  present  study,  we used the
comet assay  to investigate  the  concentration-  and  time-dependent  genotoxicity  proﬁles  of
the three  metabolites  and  the  cross-linking  potential  of MBO in human  hepatocyte  L02  cells.
For the  incubation  time  of  1 h, all metabolites  showed  positive  concentration-dependent
proﬁles  with a potency  rank  order  of IP-3,4-O  > MBO  >  IP-1,2-O.  In  human  hepatocellu-
lar  carcinoma  (HepG2)  and human  leukemia  (HL60)  cells,  IP-3,4-O  was  still more  potent
in inducing  DNA  breaks  than  MBO at high  concentrations  (>200  M), although  at low
concentrations  (≤200  M)  IP-3,4-O  exhibited  slightly  lower  or  similar  potency  to  MBO.
Interestingly,  their  time-dependent  genotoxicity  proﬁles  (0.5–4  h) in L02  cells  were  differ-
ent from  each  other:  IP-1,2-O  and  MBO  (200  M)  exhibited  negative  and positive  proﬁles,
respectively,  with  IP-3,4-O  lying in between,  namely,  IP-3,4-O-caused  DNA  breaks  did
not change  over  the exposure  time.  Further  experiments  demonstrated  that  hydrolysis  of
IP-1,2-O contributed  to the negative  proﬁle  and  MBO  induced  cross-links  at high  concen-
trations  and  long  incubation  times.  Collectively,  the  results  suggested  that  IP-3,4-O  might
play a signiﬁcant  role in the toxicity  of isoprene.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  underthe CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).Abbreviations: DEB, 1,2,3,4-diepoxybutane; DMEM,  Dulbecco’s Modiﬁed Eagl
human  hepatocellular carcinoma cells; HL60, human leukemia cells; IMDM, Isco
IP-3,4-O, 2-(1-methylethenyl)oxirane; MBO, 2-methyl-2,2′-bioxirane; mCPBA, m-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium  bromide; PBMCs, peripheral
of  DNA in the tail.
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. Introduction
Isoprene (2-methyl-1,3-butadiene), the 2-methyl ana-
og  of human carcinogen 1,3-butadiene, is an important
etrochemical that is primarily used in the manufacture
f synthetic rubber. It is also a natural product that is pro-
uced  by plants, animals [1,2], bacteria [3], and humans
4,5].
Isoprene is a possible carcinogen. Animal toxicology
tudies have indicated that it is carcinogenic to mice [6]
ut  is very weakly carcinogenic to rats [7]. Isoprene is clas-
iﬁed  as “possibly carcinogenic to humans (group 2B)” by
he  International Agency for Research on Cancer [8] and
s  “reasonably anticipated to be a human carcinogen” by
he  U.S. National Toxicology Program [9]. However, it has
ot  been classiﬁed as a human carcinogen due to lack of
pidemiological data.
The  environmental sources of isoprene include natural
nd anthropogenic ones. Emissions from plants are the pri-
ary  source of isoprene in the atmosphere; the quantities
f  emissions from plants exceed those produced syntheti-
ally  by approximately 300-fold [2]. In fact, isoprene is the
ingle  largest biogenic nonmethane hydrocarbon emitted
nto  the Earth’s atmosphere; the annual global emission is
stimated  to be ∼6 × 1011 kg [10]. The major anthropogenic
ources are combustion processes, including biomass burn-
ng,  tobacco smoking, and automobile exhaust [9,11,12].
hus, like 1,3-butadiene, isoprene is also ubiquitous in the
nvironment; its concentration in U.S. ambient air ranges
rom  1 to 21 ppb and generally is less than 10 ppb [9].
Human exposure to isoprene is largely caused by its
eneration through endogenous processes, because it is
he  major endogenously produced hydrocarbon [1] and is
bundant  in human breath at concentrations in the range
f  50–1000 ppb [13]. Nonetheless, smoking signiﬁcantly
ncreases human exposure to isoprene because tobacco
moke is the primary source of isoprene in indoor air
9,14]. Isoprene is one of the major hazardous volatile
rganic compounds in cigarette smoke; its total yield
∼800  g/cigarette) is the second largest among 14 haz-
rdous volatile organic compounds [12]. It is ranked third
after  1,3-butadiene and acetaldehyde) with respect to can-
er  hazards stemming from smoking by the World Health
rganization on the basis of its abundance in cigarette
moke and its animal carcinogenicity [15].
Similarly to 1,3-butadiene, isoprene undergoes
xidative metabolism, which is primarily mediated
y cytochrome P450 2E1, followed by P450 2B6 [16],
o  produce two isomeric monoepoxides, 2-ethenyl-2-
ethyloxirane (i.e., isoprene-1,2-oxide, IP-1,2-O) and
-(1-methylethenyl)oxirane (i.e., isoprene-3,4-oxide,
P-3,4-O). Both monoepoxides can be further metabolized
o  the diepoxide, 2-methyl-2,2′-bioxirane (MBO) (Fig. 1)
16–19].  The epoxides can be hydrolyzed by epoxide
ydrolase to form the corresponding diols or epoxydiols,
r can be conjugated with glutathione [16,20,21]. For the
wo  monoepoxides, IP-1,2-O is the major metabolite and
P-3,4-O  is the minor one (∼20%) [16–18].
Isoprene itself is not mutagenic as examined by
he Ames test, even after metabolic activation using
at liver microsomes [22]. Unlike the monoepoxide ofFig. 1. The metabolism pathways of isoprene.
1,3-butadiene, IP-1,2-O and IP-3,4-O are non-mutagenic
[23,24]. However, MBO  was found to be as mutagenic as
1,2,3,4-diepoxybutane (DEB) [23,24], the diepoxide of 1,3-
butadiene.  On the other hand, isoprene itself did not induce
strand  breaks in the absence of metabolic activation but
did  so with metabolic activation in peripheral blood mono-
nuclear  cells (PBMCs) and human leukemia cells (HL60) as
evaluated  by the comet assay [25]. This may  indicate that
isoprene  metabolites are genotoxic. Indeed, IP-1,2-O has
been  found to be genotoxic in PBMCs and HL60 [25,26].
However, so far the genotoxicity of IP-3,4-O and MBO  has
not  been examined yet.
In comparison with 1,3-butadiene, the presence of the
extra  methyl group in isoprene has a profound inﬂu-
ence on properties of its metabolites, including reactivity,
mutagenicity, etc., because the methyl group causes steric
hindrance and also introduces an asymmetric factor in
these  molecules. Due to the asymmetry, there exist two
monoepoxides that show quite distinct reactivity in some
reactions. For instance, IP-1,2-O is easily hydrolyzed,
whereas IP-3,4-O (and also MBO) is much more resistant to
hydrolysis.  Their half-lives at physiological pH and temper-
ature  are 1.25 and 73 h (46 h for MBO), respectively [23,24].
The  difference between IP-1,2-O and IP-3,4-O is espe-
cially great in the acid-catalyzed hydrolysis; the hydrolysis
rate  constant of IP-1,2-O is 10,000-fold larger than that
of  IP-3,4-O [27]. For MBO, the asymmetry renders the
reactivity of the two oxirane rings different, which was
thought to result in suppressed cross-linking potential of
MBO  compared to DEB (however, the studies were con-
ducted  through the reactions between MBO  and model
compounds (valine methyl ester or purines) and the cross-
linking  potential of MBO  has not been examined in cells or
in  vivo) [2].
Due  to the presence of reactive oxirane moieties in these
molecules, IP-1,2-O and IP-3,4-O are alkylating agents
gy Repo38 Y. Li et al. / Toxicolo
and can react with nucleobases. Their reactions with 2′-
deoxyguanosine and 2′-deoxyadenosine under in vitro
physiological conditions have been reported [28,29]. They
can  also react with N-terminal valine in hemoglobin to form
adducts  [30]. The reactivity of these epoxides toward nucle-
obases  may  be the molecular basis for their mutagenicity
and genotoxicity.
In  the present study, we set out to investigate the
genotoxic potential of IP-1,2-O, IP-3,4-O, and MBO, and
also  the cross-linking one of MBO  in human hepatocyte
L02 cells. Since the genotoxic and cross-linking poten-
tial  of a chemical depends on its concentration and also
exposure time, we investigated the concentration- and
time-dependent genotoxicity proﬁles of IP-1,2-O, IP-3,4-
O,  and MBO, and the concentration- and time-dependent
cross-linking proﬁles of MBO. Because the genotoxicity
of IP-3,4-O was unusually high, we also examined the
concentration-dependent proﬁles of all three metabolites
in  human hepatocellular carcinoma (HepG2) and human
leukemia (HL60) cells to conﬁrm it. The selected exper-
imental means was the comet assay, i.e., single cell gel
electrophoresis (SCGE), which is a standard technique to
test  the genotoxic potential of chemicals. Comet assay
has  been widely used in biomonitoring of human popu-
lations, molecular epidemiology, and assessment of DNA
damage/repair and oxidative stress [31–33]. It detects DNA
strand  breaks through measuring the rate of DNA migration
in  agarose gel and is capable of examining the presence of
cross-links  by using a second genotoxicant [31].
2. Materials and methods
2.1.  Reagents
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM), Iscove’s
Modiﬁed Dulbecco’s Medium (IMDM), and fetal bovine
serum (FBS) were obtained from Life Technologies
(GIBCO®) (Grand Island, NY, US). Isoprene was obtained
from TCI Shanghai (Shanghai, China). IP-1,2-O (CAS#
1838-94-4, 97%) and m-chloroperbenzoic acid (mCPBA,
70–75%) were purchased from Alfa Aesar (Ward Hill,
MA,  US). IP-3,4-O (CAS# 7437-61-8, Cat. No. C7500,
purity ≥95%) was obtained from Cheminstock Ltd.
(Shanghai, China, http://www.chem-in-stock.com). 3-(4,5-
Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide  (MTT), Triton X-100, agarose, propidium iodide, and
methyl  methanesulfonate (MMS)  were purchased from
Sigma–Aldrich (St. Louis, MO,  US). Other reagents, which
were  of analytical reagent grade, were obtained from
Sinopharm Chemical Reagent Company (Shanghai, China).
IP-1,2-O,  IP-3,4-O, and MBO  were dissolved in dimethyl
sulfoxide (DMSO) to prepare the stock solutions. The
working solutions, which were prepared just before exper-
iments  to avoid hydrolysis, were obtained by diluting the
stock  solutions by 1000-fold with DMEM or IMDM.
MBO  (the mixture of four optical isomers, CAS# 6341-
85-1) was synthesized from isoprene and mCPBA based on
a  procedure described in the literature with a few modiﬁca-
tions  [19]. Brieﬂy, isoprene (6.8 g, 100 mmol) was dissolved
in  550 mL  of dichloromethane in an ice-water bath and
mCPBA (51.8 g, 70–75%, 220 mmol) was added in portions.rts 1 (2014) 36–45
The  ice-water bath was removed and the mixture was
stirred at ambient temperature for 24 h. The suspension
was  then left in a freezer for 1 h and ﬁltered. The ﬁltrate was
washed  twice with 5% Na2SO3 solution and then twice with
saturated Na2CO3 solution, and dried over Na2SO4. After
solvent was removed, MBO  (4.3 g, yield 43%) was obtained.
Pure MBO  (∼100% based on the 1H NMR  spectrum) was
obtained through distillation under water pump pressure
(45 ◦C/32 mmHg). The 1H NMR  data, which showed that the
obtained MBO  consisted of two  isomers with a ratio of 3:2,
were  well consistent with those reported by Bogaards et al.
[16].
2.2.  Cell culture
The  immortalized human normal hepatocyte cell line
L02,  human hepatocellular carcinoma cell line (HepG2),
and human leukemia cell line (HL60) were obtained from
the  Center of Cell Resources of the Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences. The L02
cell  line has been used in many studies to examine the
biological effects of xenobiotics and investigate the intra-
cellular  signaling pathways (see references cited in our
previous work [34] and also other papers from our labo-
ratory  [35,36]). Isoprene is primarily metabolized in liver,
it  is thus reasonable to use liver cell lines to investigate the
genotoxicity of isoprene metabolites. In addition, we have
investigated the genotoxicity of 1,3-butadiene metabolites
on  the L02 cell line [34,37,38], therefore, using the L02
cell  line will facilitate comparison of the results between
1,3-butadiene metabolites and isoprene ones.
L02 and HepG2 cells were cultured as monolayers
in DMEM supplemented with 10% FBS and antibiotics
(100 U/ml penicillin and 100 g/ml streptomycin) in a
humidiﬁed incubator at 37 ◦C in 5% CO2 and routinely
passaged by trypsinization when nearly conﬂuent. When
cells  grew to ∼80% conﬂuence, the culture media were
discarded, and freshly prepared media containing tested
chemicals (the media were FBS-free for incubations within
12  h, but contained 10% FBS for incubations for 12 h
or  longer time) were supplemented. Cells were then
incubated at 37 ◦C for indicated times. HL60 cells were sim-
ilarly  cultured in IMDM supplemented with 12% FBS and
antibiotics. When reaching ∼80% conﬂuence, cells were
harvested through centrifugation at 1200 rpm for 2 min.
The  culture media were discarded and cells were treated
with  freshly prepared media containing tested chemicals.
2.3.  Cytotoxicity
Cytotoxicity was  assessed with the MTT  assay. Cells
were exposed to tested chemicals at 37 ◦C for speciﬁed
times. Then, the media were removed and a solution of
10  l MTT  (5 mg/ml) in 90 l FBS-free DMEM per well
was  added. After incubation at 37 ◦C for 4 h, the media
were discarded and 100 l DMSO per well was added. The
plates  were shaken at ambient temperature for 3 min, and
the  optical density at 490 nm was  recorded. In controls,
cells were exposed to vehicle only. Viability was calculated
relative to the controls. Six independent samples were
used.
gy Reports 1 (2014) 36–45 39
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.4. Comet assay
Standard  comet assay (i.e., alkaline comet assay) was
erformed as described previously [34,38]. Brieﬂy, after
xposure to tested chemicals, L02 and HepG2 cells were
ubsequently harvested by trypsinization, and HL60 cells
ere  harvested through centrifugation. Cells were washed
nce  with D-Hank’s solution and then resuspended in FBS-
ree  media. Approximately 30,000 cells per sample were
sed,  which were suspended in 30 l media and mixed
ith 140 l low melting point agarose (1%). Lysis of cells
as  performed in the lysis solution (2.5 M NaCl, 100 mM
DTA,  10 mM Tris, pH 10; 1% Triton X-100 and 10% DMSO
ere  added fresh) at 4 ◦C for 1 h. DNA was unwound in
he  electrophoresis solution (300 mM NaOH, 1 mM EDTA,
H  > 13) at 4 ◦C for 40 min  and subsequently electropho-
ised in this solution at 25 V (∼300 mA)  for 20 min. After
eutralization with 400 mM Tris (pH 7.5) and staining with
0  l PI (5 g/ml), DNA was analyzed under a ﬂuorescence
icroscope (Olympus BX-51, Japan).
To detect cross-links, a second genotoxic agent, MMS,
as  employed as recommended by the international
xpert panel for comet assay [31]. The second genotoxic
gent generates additional strand breaks and cross-links
nduced by a chemical can be detected through retardation
n  the rate of DNA migration. For chemicals that can simul-
aneously induce both strand breaks and cross-links, it is
ritical  that DNA damage caused by the second genotoxic
gent must be severe enough, otherwise the retardation
n the rate of DNA migration caused by the tested chem-
cals  may  be unable to be observed [34]. Like DEB, MBO
s  a bifunctional alkylating agent and can simultaneously
ause strand breaks and cross-links. We  already found,
hen insufﬁcient concentrations of MMS  were used, the
ates  of DNA migration kept increasing with the increase in
he  MBO  concentration and thus MBO-induced cross-links
ailed to be observed. An experiment was thus carried out
o  search for an appropriate MMS  concentration. Based on
he  result of this experiment, 500 M MMS  was selected,
hich could cause such severe DNA damage at 1 h that the
ate  of DNA migration reached 70–80%.
It has been demonstrated that adding the second geno-
oxic  agent to cells before or after treatment with the
ross-linking agent gave similar results [39]. Therefore, in
he  present study, cells were exposed to different concen-
rations of MBO  (10, 50, 200, 500, and 1000 M)  ﬁrst for
peciﬁed times and then to 500 M MMS  for 1 h. The cells
ere  then harvested and subjected to the standard comet
ssay  as described above.
.5.  Statistical analyses
DNA  percentage in the tail (%Tail DNA) was used as the
etric  for quantiﬁcation of DNA migration based on its
pparent advantages over other metrics [32,33,40–43]. One
undred  cells per glass slide were selected randomly and
he  images of comets were analyzed using CASP image-
nalysis software to obtain the quantitative data [44]. Each
lass  slide represented one independent sample. The intra-
ample  data in our experiments did not show normal
istributions, as a result, medians, instead of arithmeticdifferent exposure times as measured by the MTT  assay (IP-1,2-O did not
exhibit cytotoxicity up to 1000 M and 12 h, and thus its data were not
shown) (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001).
means, were extracted from the data and were subse-
quently used in the analyses of results as recommended by
biostatisticians [43,45]. The values presented in the present
study  were the means and standard deviations (SD) of at
least  three independent samples. Student’s t-test was  used
to  examine the statistical signiﬁcances of the differences
between two  groups of data. A p-value smaller than 0.05
was  considered to indicate the statistical signiﬁcance.
3. Results
3.1. Cytotoxicity of IP-1,2-O, IP-3,4-O, and MBO
Because DNA damage can lead to cell death, it is
critical that the highest dose tested in the comet assay
does not induce excessive cytotoxicity. Therefore, cyto-
toxicity of IP-1,2-O, IP-3,4-O, and MBO  was assessed
with the MTT  assay. Human hepatocyte L02 cells were
exposed to the three chemicals at 10, 50, 200, 500, and
1000  M for 1 h and no cytotoxicity was observed (data
not  shown). When cells were incubated with the chem-
icals  for 4 h, only MBO  exhibited slight cytotoxicity at
high  concentrations (500 and 1000 M;  the correspond-
ing viability was  94% and 76%, respectively) (Fig. 2). With
longer  incubation time (12 h), IP-1,2-O still did not show
any  cytotoxicity, however, IP-3,4-O and MBO  exhibited
concentration-dependent cytotoxicity (Fig. 2). While IP-
3,4-O  exhibited statistically signiﬁcant effects starting from
10  M,  MBO  did so from 200 M.  At the highest concentra-
tion (1000 M),  the viability was 78% and 67% for IP-3,4-O
and MBO, respectively.
3.2.  Concentration-dependent genotoxicity proﬁles of
IP-1,2-O, IP-3,4-O, and MBO as measured by the standard
comet assay
To  examine the genotoxic potential of IP-1,2-O, IP-
3,4-O, and MBO  at different concentrations, L02 cells
were incubated with the chemicals at 10, 50, 200, 500,
and  1000 M for 1 h. The concentrations and incuba-
tion time were selected to facilitate comparison with the
40 Y. Li et al. / Toxicology Reports 1 (2014) 36–45
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results obtained previously using 1,3-butadiene metabo-
lites  [34,37,38]. The values for the controls were within the
historical  records in our laboratory.
As shown in Fig. 3, the three metabolites were all geno-
toxic. However, they exhibited rather different potency,
especially at high concentrations (>200 M).  Among the
metabolites, IP-1,2-O had the lowest potency; it caused
statistically signiﬁcant effects on the rates of DNA migra-
tion  starting from 200 M.  At the highest concentration
tested, the increase in the rate of DNA migration over the
control  was only moderate (16.7% vs. 6.2% of the con-
trol,  p < 0.05). In contrast, IP-3,4-O exhibited the highest
genotoxic potential; it was considerably more potent than
IP-1,2-O  at each concentration tested. At 10 M,  IP-3,4-O
already induced an increase in the rate of DNA migration
over the control, although the increase was not statisti-
cally signiﬁcant (p = 0.1). Starting from 50 M,  the increases
in  the rates of DNA migration became statistically signiﬁ-
cant.  At 1000 M,  IP-3,4-O caused a large increase in the
rate  of DNA migration over the control (69.8% vs. 6.2% of
the  control, p < 0.001). Actually, 1000 M IP-3,4-O caused
such  great DNA damage that the rate of DNA migration
has been close to the maximum (theoretically 100%, but
practically 80–90%). Interestingly, the genotoxic potential
of  MBO  was lower than that of IP-3,4-O. MBO  caused sta-
tistically signiﬁcant increases in the rates of DNA migration
starting from 200 M.  At 1000 M,  MBO  induced a rate of
DNA  migration at approximately 50% (Fig. 3). Therefore, the
three  metabolites showed a potency rank order of IP-3,4-
O  > MBO  > IP-1,2-O.
Because the genotoxicity potential of IP-3,4-O was
unexpectedly high, in particular, higher than MBO, the
three  metabolites were also tested in HepG2 and HL60
cell  lines. Overall, IP-1,2-O, IP-3,4-O, and MBO  all exhibited
similar proﬁles to those observed in L02 cell line (Fig. 4). IP-
1,2-O  was still the weakest genotoxicant among the three
chemicals. However, the relative potency of IP-3,4-O and
MBO  depended on the concentrations. At high concen-
trations (>200 M),  IP-3,4-O was still more potent than
MBO; however, at low concentrations (≤200 M),  MBOMBO  at different concentrations with the incubation time being 1 h in
HepG2 and HL60 cells as measured by the standard comet assay (*p ≤ 0.05,
**p  ≤ 0.01, ***p ≤ 0.001).
showed the same potency as IP-3,4-O in HepG2 cells, and
slightly  higher potency than IP-3,4-O in HL60 cells (Fig. 4).
Nonetheless, it was  conﬁrmed that IP-3,4-O still exhibited
surprisingly high genotoxicity potential in HepG2 and HL60
cell  lines, which was  comparable or even higher than MBO.
3.3.  Time-dependent genotoxicity proﬁles of IP-1,2-O,
IP-3,4-O, and MBO
To  examine how the rate of DNA migration caused by
the  metabolites changed with the incubation time, L02 cells
were  exposed to IP-1,2-O, IP-3,4-O, and MBO  for 0.5, 1, 2,
and  4 h. For IP-1,2-O, the highest concentration (1000 M)
was  used. For IP-3,4-O, two lower concentrations (200 and
500  M),  rather than 1000 M,  were selected. The rate of
DNA  migration caused by 1000 M IP-3,4-O has been close
to  the maximum (Fig. 3); as a result, there may  not be
sufﬁcient room for further increases. For MBO, 200 and
1000  M MBO  were tested.
The results showed that the three metabolites exhib-
ited different time-dependent proﬁles. For IP-1,2-O, the
rate  of DNA migration was the greatest at the ﬁrst time
point (0.5 h), and then decreased with the increase in the
incubation time (Fig. 5). That is, IP-1,2-O showed a nega-
tive  time-dependent genotoxicity proﬁle. When cells were
exposed  to IP-1,2-O for 4 h, the observed rate of DNA
migration was close to that in the control, although the
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of IP-1,2-O. Human hepatocyte L02 cells were incubated with 1000 M
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as  tested for 1000 M MBO) as measured by the standard comet assay
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001).
ifference was still statistically signiﬁcant. Longer incu-
ation  time led to a lower rate of DNA migration; when
ells  were incubated with 1000 M IP-1,2-O for 12 h, the
ate  of DNA migration showed no statistically signiﬁcant
ifference from that in the control (data not shown).
The situation was different for IP-3,4-O. The rate of
NA  migration induced by 200 M IP-3,4-O virtually did
ot  change over the incubation time (Fig. 5). Although it
eemed  that the rate of DNA migration decreased very
lightly with the increase in the incubation time, the
ecreases were not statistically signiﬁcant at all. The result
btained with 500 M IP-3,4-O was similar; the rate of DNA
igration kept unchanged over the incubation time (data
ot  shown).
MBO  represented the third situation. Its time-
ependent genotoxicity proﬁle depended on the
oncentration. At 200 M,  MBO  exhibited a positive
roﬁle, namely, the MBO-induced rate of DNA migra-
ion increased with the increase in the incubation time.
owever, 1000 M MBO  produced a mixed proﬁle, which
onsisted of a positive one from 0.5 to 2 h and then a
egative one from 2 to 4 h (Fig. 5). An increase in the incu-
ation  time from 2 h to 4 h led to a statistically signiﬁcant
ecrease in the rate of DNA migration. To conﬁrm the
ecrease, an additional time point (6 h) was examined.
ndeed, the rate of DNA migration at 6 h was smaller
han that at 2 h and the decrease was also statistically
igniﬁcant (p < 0.05), although the data at 6 h showed no
tatistically signiﬁcant difference from that at 4 h (Fig. 5).
.4. Hydrolysis of IP-1,2-O contributed to its negative
ime-dependent genotoxicity proﬁle
It was somewhat unexpected that IP-1,2-O gave a nega-
ive  time-dependent genotoxicity proﬁle. Usually, one will
xpect  a positive proﬁle for a DNA-alkylating agent. After
ll,  longer incubation time means that more sites on DNA
re  alkylated and thus more strand breaks are produced.
e  speculated that the negative proﬁle of IP-1,2-O may  be1000 M IP-1,2-O for 2 and 4 h, but the IP-1,2-O-containing media were
replaced with freshly prepared media every hour (which were indicated
by 2R and 4R) (*p ≤ 0.05, **p ≤ 0.01).
attributable to its rapid hydrolysis in solution, because the
half-life  of IP-1,2-O, which was reported as 1.25 h at pH 7.4
and  37 ◦C [23,24], was comparable to the time scales in our
experiments. A simple calculation indicated that 76% of IP-
1,2-O  remained at 0.5 h, 57% did at 1 h, and only one third
did  at 2 h.
To  examine the speculation, an experiment with the
media in the cell cultures being replaced frequently using
freshly  prepared ones was  performed. Speciﬁcally, for the
L02  cells being exposed to IP-1,2-O for 2 and 4 h, the media,
which contained 1000 M IP-1,2-O, were replaced with
freshly prepared ones every hour. The result was shown in
Fig.  6. Indeed, as speculated, the L02 cells with the media
being replaced every hour showed considerably greater
rates  of DNA migration than those treated regularly, and
the  differences were statistically signiﬁcant (both p < 0.01;
see  Fig. 6, compare the data at 2 and 2R, and at 4 and
4R). Moreover, these cells also exhibited greater rates of
DNA  migration than those being incubated for 1 h, and
the  differences were statistically signiﬁcant as well (see
Fig.  6, compare the data at 1 and 2R (p < 0.05), and at 1 and
4R  (p < 0.01)). That is to say, when cells were constantly
exposed to freshly prepared media, the rate of DNA migra-
tion  caused by IP-1,2-O increased with the increase in the
exposure  time. In other words, the time-dependent pro-
ﬁle  of IP-1,2-O was reversed from negative to positive in
this  situation. Thus, the results suggested that the neg-
ative  proﬁle of IP-1,2-O could be attributed to its rapid
hydrolysis.
3.5.  MBO induced DNA cross-linking at high
concentrations and long incubation timesMBO at 1000 M caused a decrease in the rate of DNA
migration when the incubation time was increased from 2 h
to  4 or 6 h (Fig. 5), suggesting that MBO  induced DNA cross-
linking, because the decreases could not be attributed to
42 Y. Li et al. / Toxicology Repo
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Fig. 7. Exposure to high concentrations of MBO  for long time led to
decreases in the rates of DNA migration caused by MMS  in human hep-
atocyte L02 cells. Cells were exposed to different concentrations of MBO
for  6 h and then 500 M MMS  for 1 h, and subsequently were subjected
to the standard comet assay. Inset: Cells were incubated with 1000 M
MBO  for 4 h and then 500 M MMS  for 1 h, and were subjected to the
standard comet assay. Lower concentrations of MBO  did not show any
statistically signiﬁcant effects, as a result, the data were not shown. As a
positive control, cells were incubated with DEB (500 M,  1 h) and then
MMS  (*p ≤ 0.05, **p ≤ 0.01).
hydrolysis of MBO  due to its long half-life (46 h) [23,24].
To  conﬁrm the presence of cross-links, L02 cells were incu-
bated  with different concentrations of MBO  (10, 50, 200,
500,  and 1000 M)  for 1, 2, 4, and 6 h, and subsequently
500 M MMS  for 1 h.
The results indicated that MBO  failed to cause any retar-
dation in the rate of MMS-induced DNA migration when
cells  were incubated with MBO  for 1 or 2 h. However, under
these  conditions, the positive control (500 M DEB) [34]
led  to a large decrease in the rate of DNA migration (which
was  statistically signiﬁcant) (data not shown). Therefore,
MBO  did not induce detectable cross-links when the incu-
bation  time was 1 or 2 h. With the incubation time being
4  h, only 1000 M MBO  was observed to cause a small
but statistically signiﬁcant decrease (72.1% vs. 79.7% of the
control,  p < 0.05) in the rate of MMS-induced DNA migra-
tion  (the inset in Fig. 7). When the incubation time was
increased to 6 h, the effect became stronger; both 500 and
1000  M MBO  caused statistically signiﬁcant decreases
in the rates of MMS-induced DNA migration (57.2% and
54.2%,  respectively, vs. 72.3% of the control, both p < 0.01).
Therefore, the experiments using MMS  not only conﬁrmed
the  formation of MBO-induced cross-links, but also deter-
mined  the conditions that detectable DNA cross-links were
formed:  1000 M MBO  for 4 h, and 500 and 1000 M MBO
for  6 h.
4.  Discussion
In the present study, we investigated the concentration-
and time-dependent genotoxicity proﬁles of two monoe-
poxides and the diepoxide of isoprene in human hepato-
cyte  L02 cells using the comet assay. The results indicated
that  the three metabolites all induced strand breaks
in a concentration- and time-dependent manner, thusrts 1 (2014) 36–45
exhibiting genotoxicity. Interestingly, each metabolite
showed unique features. Their genotoxic potency, which
apparently depended on the concentration and incubation
time, was  quite distinct.
The  concentration-dependent proﬁles of the three
metabolites were all positive; however, their relative
potency was rather different. In human hepatocyte L02
cells,  IP-1,2-O and IP-3,4-O had the lowest and high-
est potential to induce strand breaks, respectively, with
MBO  lying in between. IP-3,4-O was more potent than
both  IP-1,2-O and MBO, especially at high concentrations
(≥200 M).  In HepG2 cells, the above observation still
stood, although virtually there was  no difference between
IP-3,4-O and MBO  at low concentrations (≤200 M). In
HL60  cells, MBO  was slightly more potent than IP-3,4-O
at  low concentrations (≤200 M),  however, IP-3,4-O still
exhibited higher potential to induce strand breaks at high
concentrations (>200 M),  especially at 1000 M. Overall,
among the three metabolites, IP-1,2-O was clearly the least
potent  in all three cell lines at all concentrations tested;
at  high concentrations (>200 M),  IP-3,4-O was undoubt-
edly the most potent in all three cell lines with MBO lying
in  between. At low concentrations (≤200 M),  depending
on the cell line, the relative potency of IP-3,4-O and MBO
varied.
It  was beyond our expectation that IP-3,4-O had high
potential to induce strand breaks. As it was  unexpected,
we ﬁrst considered the possibility that the effect observed
with  IP-3,4-O was caused by some highly toxic impurities
in  the reagent. The purity of the reagent was 95.2% as deter-
mined  by GC and the major impurity was  dichloromethane
(the residual solvent in the synthesis of IP-3,4-O, 1.5%). Its
1H NMR  spectrum indicated that the reagent had excellent
purity and few peaks of impurities except dichloromethane
were visible. Removal of dichloromethane by rotary evapo-
ration,  which was conﬁrmed by the 1H NMR  spectrum, had
no  effect on the genotoxic potential of IP-3,4-O. Further-
more, we synthesized a small quantity of IP-3,4-O through
the  reaction of isoprene and mCPBA with a molar ratio of
1:1  in dichloromethane. This was a poor reaction because
it  was  of low yield (the total yield of monoepoxides in
our  experiment was about 11%) and produced two  monoe-
poxides with IP-1,2-O being the predominant product (the
molar  ratio of IP-1,2-O and IP-3,4-O in our synthesis was
∼4:1,  consistent with the literature [46]). The rationale
behind the synthesis of IP-3,4-O using such a poor reac-
tion  was, if the reagent of IP-3,4-O did contain traces of
highly  genotoxic chemicals that were the residual reac-
tants  or were byproducts in the synthesis, the IP-3,4-O
synthesized by ourselves would not contain these traces of
chemicals  because commercially IP-3,4-O would certainly
not  be synthesized using such a poor reaction (the com-
mercial synthesis of IP-3,4-O probably uses the method
reported by Harwood et al. [47]. It is a simple one-step
reaction with a moderate yield). Because IP-1,2-O was the
predominant product, in our synthesis, the IP-3,4-O, which
was  obtained by distillation, contained ∼8% IP-1,2-O as
indicated by the 1H NMR  spectrum. Despite the moder-
ate purity, it produced a very similar result in L02 cells to
IP-3,4-O  obtained commercially. Therefore, the possibility
that  the strand breaks induced by the reagent of IP-3,4-O
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ere caused by impurities in the reagent could safely be
xcluded.  That is to say, IP-3,4-O did have high potential in
nducing  strand breaks.
This  was the most surprising ﬁnding in the present
tudy. In fact, with the incubation time being 1 h, the
enotoxic potential of IP-3,4-O in L02 cell line was not
nly  the highest among the three metabolites of isoprene,
ut  also exceeded that of monoepoxide and epoxydiol of
,3-butadiene and 1-chloro-2-hydroxy-3-butene (an alter-
ative  metabolite of 1,3-butadiene), and was similar to
hat  of DEB (however, only the data at 50 and 200 M
hould be used to compare with DEB, because the rates
f  DEB-induced DNA migration at higher concentrations
ere smaller than that at 200 M due to cross-linking)
34,37,38]. IP-3,4-O has low alkylating ability, which is only
ne  tenth of MBO, and is thus non-mutagenic [24]. It has
een  demonstrated that mutagenicity of epoxides, as mea-
ured  by the Ames test, was positively correlated with their
lkylating ability [24]. This appears reasonable because the
ormation  of DNA adducts is generally considered to be cen-
ral  to initiating the mutagenic process for DNA-reactive
hemicals [48]. However, the formation of DNA adducts
hould also be the basis for genotoxicity of such chemicals.
herefore, it was surprising that IP-3,4-O had low alkylating
bility and no mutagenicity but exhibited high genotoxic-
ty.  This might imply that other mechanisms are involved in
he  genotoxicity of IP-3,4-O. Bogaards et al. found that MBO
ould  not explain the observed interspecies differences in
he  toxicity between mouse and rat, and thus assumed that
ther  metabolites may  play a role [49]. Because IP-1,2-O is
asily  hydrolyzed and thus has low toxicity, and the in vivo
oncentrations of MBO  might be very low [5], it is possible
hat  IP-3,4-O plays an important role in the toxicity of iso-
rene.  Further studies should be conducted to address the
ssue.
Interestingly, the time-dependent proﬁles of the three
etabolites exhibited trends different from each other. IP-
,2-O  showed a negative proﬁle, whereas MBO  (200 M)
ave  a positive one, with IP-3,4-O lying in between, that is,
he  rate of DNA migration did not change over the incuba-
ion  time. In addition, 1000 M MBO  gave rise to a decrease
n  the rate of DNA migration for the incubation time of 4 h
n  comparison with that of 2 h.
To explain the time-dependent proﬁle, it should be
oted that the rates of DNA migration observed in the
xperiments actually represented the combined results of
trand  breaks and DNA repair. Alkylating agents induce
trand breaks, which are repaired by the DNA repair
achinery. The amounts of strand breaks induced by alkyl-
ting  agents increase with time, therefore, how the rates
f  DNA migration observed in the experiments change
ith time is dependent upon the relative capability of
lkylating agents and the DNA repair machinery. Strong
lkylating agents cause rapid increases in the amounts of
trand  breaks over time, which overwhelm the capacity of
he  DNA repair machinery. As a result, the rates of DNA
igration observed increase over time. MBO  falls into thisategory,  because it has high alkylating ability [24]. On
he  other hand, the amounts of strand breaks caused by
eak  alkylating agents also increase with time, however,
f  production of strand breaks is overwhelmed by the DNArts 1 (2014) 36–45 43
repair  machinery, the rates of DNA migration observed will
decrease  with time. This may  explain the situation of IP-
1,2-O.  IP-1,2-O itself is a much weaker alkylating agent than
MBO  [24], and it is easy to be hydrolyzed. The two fac-
tors  together lead to the negative time-dependent proﬁle
of  IP-1,2-O. Indeed, the experiment replacing the IP-1,2-O-
containing media demonstrated that its hydrolysis was the
major  contributor to the observed phenomenon. In addi-
tion,  one can expect a third case, namely, when the amounts
of  production of strand breaks are more or less the same as
those  repaired by the DNA repair machinery, the rates of
DNA  migration observed will not change with time. It might
be  the case of IP-3,4-O.
However,  obviously the negative proﬁle of 1000 M
MBO  from 2 to 4 h could not be explained by the above
mechanism, because MBO  is a strong alkylating agent, plus,
a  high concentration was used. This phenomenon was
considered to be caused by the formation of cross-links,
because MBO  is a bifunctional alkylating agent. Indeed, the
experiment with MMS  conﬁrmed the formation of cross-
links  at high MBO  concentrations and long incubation
time.
It was  clear that the cross-linking potential of MBO  was
much  weaker than that of DEB. MBO-induced cross-links
were able to be detected only at high concentrations (500
and  1000 M)  and long incubation times (4 and 6 h), and
the  observed effects were not strong. Even under the best
conditions (MBO at 1000 M and the incubation time at
6  h), only a moderate decrease in the rate of DNA migra-
tion  relative to the control was  observed (54.2% vs. 72.3% of
the  control, p < 0.05). By contrast, DEB-induced cross-links
were able to be easily detected at 500, 800, and 1000 M
with  the incubation time being 1 h and the effects were
strong; 1000 M DEB reduced the rate of MMS-induced
DNA migration from 63.7% of the control to 3.0% [34]. The
results  supported the proposition of Watson et al., who
expected that MBO  has lower cross-linking potential com-
pared  to DEB [2]. This was  attributed to the methyl group in
the  molecule, which suppresses the nucleophilic attack to
the  oxirane ring carrying the methyl group through steric
hindrance and instead enhances intramolecular cyclization
or  depurination [2].
In  summary, in the present study we investigated the
concentration- and time-dependent genotoxicity proﬁles
of  three isoprene metabolites and unexpectedly found that
IP-3,4-O  had surprisingly high potential to induce strand
breaks. The underlying mechanisms deserve further stud-
ies.
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